HomeCompareCDNTF vs PFE

CDNTF vs PFE: Dividend Comparison 2026

CDNTF yields 3.08% · PFE yields 6.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CDNTF wins by $313.4K in total portfolio value
10 years
CDNTF
CDNTF
● Live price
3.08%
Share price
$167.56
Annual div
$5.15
5Y div CAGR
54.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$364.5K
Annual income
$198,541.28
Full CDNTF calculator →
PFE
Pfizer Inc.
● Live price
6.20%
Share price
$27.76
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.1K
Annual income
$27,210.54
Full PFE calculator →

Portfolio growth — CDNTF vs PFE

📍 CDNTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCDNTFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CDNTF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CDNTF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CDNTF
Annual income on $10K today (after 15% tax)
$261.49/yr
After 10yr DRIP, annual income (after tax)
$168,760.09/yr
PFE
Annual income on $10K today (after 15% tax)
$526.66/yr
After 10yr DRIP, annual income (after tax)
$23,128.96/yr
At 15% tax rate, CDNTF beats the other by $145,631.13/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CDNTF + PFE for your $10,000?

CDNTF: 50%PFE: 50%
100% PFE50/50100% CDNTF
Portfolio after 10yr
$207.8K
Annual income
$112,875.91/yr
Blended yield
54.32%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

CDNTF
Analyst Ratings
2
Buy
Consensus: Buy
Altman Z
1.9
Piotroski
7/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-0.9% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CDNTF buys
0
PFE buys
0
No recent congressional trades found for CDNTF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCDNTFPFE
Forward yield3.08%6.20%
Annual dividend / share$5.15$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR54.3%13.2%
Portfolio after 10y$364.5K$51.1K
Annual income after 10y$198,541.28$27,210.54
Total dividends collected$326.3K$60.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyHold

Year-by-year: CDNTF vs PFE ($10,000, DRIP)

YearCDNTF PortfolioCDNTF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$11,175$474.68$9,161$701.38+$2.0KCDNTF
2$12,722$764.92$8,610$859.79+$4.1KCDNTF
3$14,868$1,255.78$8,366$1,081.25+$6.5KCDNTF
4$18,025$2,116.42$8,483$1,405.66+$9.5KCDNTF
5$22,987$3,700.08$9,084$1,907.24+$13.9KCDNTF
6$31,401$6,804.50$10,418$2,732.78+$21.0KCDNTF
7$47,003$13,403.97$13,007$4,193.56+$34.0KCDNTF
8$79,226$28,933.35$18,010$7,005.87+$61.2KCDNTF
9$155,100$70,327.75$28,216$12,979.89+$126.9KCDNTF
10$364,498$198,541.28$51,081$27,210.54+$313.4KCDNTF

CDNTF vs PFE: Complete Analysis 2026

CDNTFStock

Canadian Tire Corporation, Limited provides a range of retail goods and services in Canada. It operates in three segments: Retail, CT REIT, and Financial Services. The Retail segment retails automotive maintenance products and accessories, parts, tires as well as automotive repair and roadside assistance; kitchen, home organization, decor and essentials, home electronics, pet, and cleaning and consumable products; tools, hardware, paint, electrical, plumbing, home environment, and smart home products; and outdoor recreation, exercise, footwear and apparel, hunting, fishing, camping, and sporting goods. It also retails Christmas trees, lights and decor, Halloween décor and costumes, yard care and maintenance, and snow removal equipment; patio furniture, barbeques, pools, trampolines, outdoor power equipment and tools, plants and gardening supplies; backyard amusement, pool fun, and toys and games; gasoline; sporting goods and active wear; casual and industrial apparel and footwear; and outerwear, base-layer, and workwear. This segment offers its products under the Canadian Tire, Canadian Tire Gas, Mark's, PartSource, Helly Hansen, Party City, and SportChek brand names. This segment also participates in loyalty programs, as well as sells its products online. The CT REIT segment operates as a closed-end real estate investment trust that holds a portfolio of 368 properties comprising Canadian Tire stores, Canadian Tire anchored retail developments, industrial properties, a mixed-use commercial property, and development properties. The Financial Services segment provides financial and other ancillary products and services, including consumer credit cards, in-store financing, insurance products, and retail and broker deposits; and savings accounts and guaranteed investment certificates. Canadian Tire Corporation, Limited was founded in 1922 and is headquartered in Toronto, Canada.

Full CDNTF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this CDNTF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CDNTF vs SCHDCDNTF vs JEPICDNTF vs OCDNTF vs KOCDNTF vs MAINCDNTF vs JNJCDNTF vs MRKCDNTF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.